They finish Phase II trials August and we know they are progressing well. The delivery method presents some risk as to size of the valuation... if they can make it into a cream/patch then the upside is there. I'm not sure how many people would want to get a whole bunch of injections just to get a tan.
The low market cap gives a punter large upside but any problem with side affects (could be longer term) then the downside is everything.
Something like NRT already has the downside protected and you get all the upside of a cancer cure, cardio drug etc etc. NRT is much more of a sure thing than EPT.
Cheers,
Munch.
12 month target, page-7
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.39 |
Change
0.430(2.87%) |
Mkt cap ! $771.0M | |||
| Open | High | Low | Value | Volume |
| $14.96 | $15.39 | $14.83 | $2.149M | 141.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 590 | $15.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.41 | 1079 | 1 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| CUV (ASX) Chart |